BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31482338)

  • 1. Early Warning Models to Estimate the 30-Day Mortality Risk After Stent Placement for Patients with Malignant Biliary Obstruction.
    Zhou HF; Lu J; Zhu HD; Guo JH; Huang M; Ji JS; Lv WF; Li YL; Xu H; Chen L; Zhu GY; Teng GJ
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1751-1759. PubMed ID: 31482338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Prediction for Early Biliary Infection after Percutaneous Transhepatic Biliary Stent Placement in Malignant Biliary Obstruction.
    Zhou HF; Huang M; Ji JS; Zhu HD; Lu J; Guo JH; Chen L; Zhong BY; Zhu GY; Teng GJ
    J Vasc Interv Radiol; 2019 Aug; 30(8):1233-1241.e1. PubMed ID: 31208946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transhepatic placement of biliary endoprostheses: results in 100 consecutive patients.
    Dick BW; Gordon RL; LaBerge JM; Doherty MM; Ring EJ
    J Vasc Interv Radiol; 1990 Nov; 1(1):97-100. PubMed ID: 1724613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial.
    Piñol V; Castells A; Bordas JM; Real MI; Llach J; Montañà X; Feu F; Navarro S
    Radiology; 2002 Oct; 225(1):27-34. PubMed ID: 12354980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting early mortality following percutaneous stent insertion for malignant biliary obstruction: a multivariate risk factor analysis.
    Rai R; Dick R; Doctor N; Dafnios N; Morris R; Davidson BR
    Eur J Gastroenterol Hepatol; 2000 Oct; 12(10):1095-100. PubMed ID: 11057454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study.
    Yokota Y; Fukasawa M; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Kawakami S; Fukasawa Y; Sato T; Enomoto N
    BMC Gastroenterol; 2017 Oct; 17(1):105. PubMed ID: 29020933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Recurrent Biliary Obstruction Following Percutaneous Uncovered Metal Stent Insertion in Patients with Distal Malignant Biliary Obstruction: An Analysis Using a Competing Risk Model.
    Zhang JX; Wang B; Liu S; Zu QQ; Shi HB
    Cardiovasc Intervent Radiol; 2019 Feb; 42(2):276-282. PubMed ID: 30411153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction.
    Naitoh I; Ohara H; Nakazawa T; Ando T; Hayashi K; Okumura F; Okayama Y; Sano H; Kitajima Y; Hirai M; Ban T; Miyabe K; Ueno K; Yamashita H; Joh T
    J Gastroenterol Hepatol; 2009 Apr; 24(4):552-7. PubMed ID: 19220678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center.
    Li M; Bai M; Qi X; Li K; Yin Z; Wang J; Wu W; Zhen L; He C; Fan D; Zhang Z; Han G
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):709-21. PubMed ID: 25338831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting early biliary infection after stenting of malignant biliary obstruction: model development and internal validation.
    Liu Y; Zhang C; Song M; Han X; Jiao D
    Abdom Radiol (NY); 2023 Jul; 48(7):2456-2465. PubMed ID: 37160766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous biliary covered stent insertion in patients with malignant duodenobiliary obstruction.
    Lee E; Gwon DI; Ko GY; Sung KB; Yoon HK; Shin JH; Kim JH; Ko HK; Song HY
    Acta Radiol; 2015 Feb; 56(2):166-73. PubMed ID: 24518689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction.
    Kaw M; Singh S; Gagneja H
    Surg Endosc; 2003 Mar; 17(3):457-61. PubMed ID: 12404053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-expandable metal stents in malignant biliary obstruction.
    Jaganmohan S; Lee JH
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):105-14. PubMed ID: 22149586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors Increase the Risk of Early Biliary Infection After Placement of Percutaneous Transhepatic Biliary Stents.
    Xu S; Zhang XJ; Guan LJ; Li B; Wang L; Li XG
    J Vasc Interv Radiol; 2021 Apr; 32(4):569-575. PubMed ID: 33461872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial.
    Zhu HD; Guo JH; Huang M; Ji JS; Xu H; Lu J; Li HL; Wang WH; Li YL; Ni CF; Shi HB; Xiao EH; Lv WF; Sun JH; Xu K; Han GH; Du LA; Ren WX; Li MQ; Mao AW; Xiang H; Zhang KX; Min J; Zhu GY; Su C; Chen L; Teng GJ
    J Hepatol; 2018 May; 68(5):970-977. PubMed ID: 29331343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, Severity, and Risk Factors for Acute Pancreatitis After Percutaneous Transhepatic Biliary Stent Placement Across the Papilla of Vater.
    Sugawara S; Arai Y; Sone M; Katai H
    Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1904-1910. PubMed ID: 28685381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
    Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
    Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomogram for acute pancreatitis after percutaneous biliary stent insertion in patients with malignant obstruction.
    Xu C; Gu Y; Zhou W; Xu G; Liu S; Shi H
    BMC Gastroenterol; 2022 Nov; 22(1):449. PubMed ID: 36344930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of biliary endoprostheses using expandable metallic stents in obstructive jaundice--long-term results of three different types of stent].
    Wakabayashi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1571-81. PubMed ID: 1334540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based nomogram for 30-day mortality prediction for patients with unresectable malignant biliary obstruction after ERCP with metal stent: a retrospective observational cohort study.
    Zhu Z; Hu K; Zhao F; Liu W; Zhou H; Zhu Z; Li H
    BMC Surg; 2023 Aug; 23(1):260. PubMed ID: 37649027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.